National Psoriasis Foundation appoints new experts to its Medical Board
The NPF Medical Board provides guidance and leadership to the organization on all medical issues related to the psoriatic disease patient community. The board also facilitates access to quality care by advocating for better clinical research tools, promoting medical education, and identifying and promoting medical professionals who most effectively treat psoriatic disease. Learn more at www.psoriasis.org/medical-board.
Richard Fried, M.D., Ph.D., is the clinical director of Yardley Dermatology Associates in Yardley, Pennsylvania. He is board-certified in dermatology and clinical psychology with expertise as a clinician, researcher and teacher. Fried received his medical degree from the State University of New York (SUNY) Downstate Medical Center and his Ph.D. in clinical psychology from Hofstra University.Amit Garg, M.D., is the vice president of dermatology at New York’s North Shore LIJ Health System and the associate professor and founding chair of the dermatology department at Hofstra North Shore-LIJ School of Medicine in Hempstead, New York. Garg’s research interests focus on measuring and assessing patient-centered outcomes for psoriasis and psoriatic arthritis, among other autoimmune diseases. He received his medical degree from the University of Massachusetts Medical School.
Caitriona Ryan, M.D.,is the vice chair of the dermatology residency program at Baylor University Medical Center in Dallas and the clinical associate professor of dermatology at Texas A&M Health Science Center. Her primary research focus centers on how a person’s genes affect their response to certain psoriasis therapies. Additionally, Ryan has a particular interest on the impact of psoriasis on quality of life and recently published the largest clinical study on genital psoriasis and its impact on psychosexual function. She has a medical degree from University College Dublin in Ireland.
Sergio Schwartzman, M.D., is an associate professor of clinical medicine at Weill Cornell Medical College and the associate attending physician at New York-Presbyterian Hospital and the Hospital for Special Surgery, both in New York City. A rheumatologist, Schwartzman has extensive research experience in psoriatic arthritis and autoimmune diseases of the eye such as uveitis – an inflammatory disease that is linked to psoriatic disease. Schwartzman has a medical degree from the Icahn School of Medicine at Mount Sinai.
Learn more about the NPF Medical Board at www.psoriasis.org/medical-board.
About the National Psoriasis Foundation
Serving its community through more than 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $21 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure. Learn more at www.psoriasis.org.